LANCET
Sjogren’s Syndrome Drug Trial: Phase 2 Trials of Iscalimab Drug Show Positive Effects on Patients Unable To Cry or Produce Saliva
Government Spending on Healthcare Low: India Rubbishes Lancet Report, Says Spending on Healthcare is at All-Time High
12.5 Million Children, Teens Aged Between Five and 19 in India Obese in 2022, Reveals Lancet Study
Covaxin Phase 3 Trial Update: Bharat Biotech's COVID-19 Vaccine Data Shows 77% Efficacy, Says Lancent
Pfizer-BioNTech’s COVID-19 Vaccine Third Dose More Effective in Reducing Severe Coronavirus Illness: Lancet
Google Trends